Top Health-care stocks:
Health-care shares were mixed in pre-market trade Tuesday
In health-care stocks news, United Therapeutics ( UTHR ) reported pre-market Tuesday improved Q3 adjusted earnings and revenues that beat consensus forecasts compiled by Capital IQ.
Shares were unchanged at $126.03 pre-bell, towards the lower end of the 52-week trading range between $117.88 and $190.29.
Theravance Biopharma ( TBPH ) and Trek Therapeutics said today that Trek has initiated a phase 2a clinical trial of an investigational hepatitis C treatment known as TD-6450.
Shares were also flat at $12.87 pre-bell, towards the lower end of the 52-week trading range between $10.56 and $22.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.